Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

ASB-14 Inhibitors

ASB-14 inhibitors are chemical compounds that target and modulate the activity of ASB-14, a member of the ankyrin repeat and SOCS box-containing protein family. This protein family is known for its role in various cellular processes, particularly in ubiquitin-mediated protein degradation. ASB-14 specifically is associated with the regulation of the ubiquitination pathway, where it functions by interacting with cullin-RING ligases, influencing the degradation of specific protein substrates within the cell. By inhibiting ASB-14, these compounds can potentially modulate the stability and turnover of proteins that are essential to maintaining cellular homeostasis.

ASB-14 inhibitors can vary in structure, often designed to fit within the binding site of ASB-14, thereby preventing its normal interaction with its molecular partners. They may possess distinct functional groups that enable them to interact with specific amino acid residues on the ASB-14 protein, thereby altering its activity. Such inhibitors can be used as valuable tools in research to investigate the biological pathways influenced by ASB-14, including protein degradation, cell cycle control, and signal transduction. These compounds are also utilized to better understand the mechanistic role of ASB-14 in cellular functions and the broader ubiquitin-proteasome system. Their study provides insight into the fundamental molecular interactions that govern protein regulation within cells.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

As an inhibitor of the JNK signaling pathway, SP600125 could lead to a decrease in ASB-14 expression by inhibiting transcription factors downstream of JNK that are necessary for ASB-14 gene expression.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

This compound inhibits the MEK1/2 kinases, which could lead to reduced phosphorylation of downstream targets and potentially result in the downregulation of ASB-14 expression through decreased activation of transcription factors.